Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to Consumers

Phreesia, a leader in patient intake, outreach, and activation, is pleased to announce it has acquired Comsort, Inc. d/b/a MediFind (MediFind), a health technology company that uses advanced analytics to help patients—especially those with serious, chronic, and rare diseases—find better care faster. MediFind uses machine learning and proprietary algorithms to continuously review medical information across a wide range of datasets, identifying leading doctors in specific conditions and fields based on factors such as their research output, the volume of patients, and standing among their peers. MediFind assigns four levels of expertise to those doctors: elite, distinguished, advanced, and experienced. Elite-level doctors are global leaders in their field who hold leadership positions, publish and speak regularly, and are involved in cutting-edge treatments. MediFind CEO, Patrick Howie, founded the company after his brother was diagnosed with a rare cancer, and he experienced firsthand how challenging it was to find high-quality experts and treatments. “I’m incredibly proud that our platform can help sift through the noise and identify doctors at the forefront of their fields,” said Howie, who is now a Vice President of Product Management at Phreesia. “With Phreesia’s size, scale, and experience, we’re now going to be able to reach many more people, which is very exciting.” According to Rob Weker, a three-time cancer survivor and patient advocate, navigating t...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Chronic Care Comsort Inc. David Linetsky Health IT Acquisitions Healthcare M&A MediFind Patrick Howie Phreesia Rare Diseases Rob Weker Source Type: blogs